Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Terbinafine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Recipient : Moberg Pharma
Deal Size : Undisclosed
Deal Type : Collaboration
Moberg Pharma Enters Into Collaboration with Allderma for Launch in Scandinavia
Details : The agreement with Allderma complements the existing licensing agreement for MOB-015 in Europe. Allderma is responsible for marketing, distribution and sales in Sweden, Denmark and Norway, while Moberg Pharma is responsible for the manufacture and delive...
Product Name : Terclara
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
August 11, 2021
Lead Product(s) : Terbinafine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Recipient : Moberg Pharma
Deal Size : Undisclosed
Deal Type : Collaboration